Skip to main content
FinSpry Logo
FinSpry
CRSP logo
CRSP
(NASDAQ)
CRISPR Therapeutics AG
$52.26-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

CRISPR Therapeutics AG (CRSP) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for CRISPR Therapeutics AG stock.

Analyst Consensus Rating

Investment consensus from 18 professional research analysts

Consensus Rating

Buy
Based on 18 unique analysts
(19 total ratings in last 90 days)
High Confidence∞:1 Buy/Sell

Average Price Target

$72.22
↑ 35.12% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest CRSP Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Ahan Chakraborty
Zacks Equity Research
HoldInitiates Coverage
-
James Halley
The Motley Fool
BuyInitiates Coverage
-
Anthropic Biotechnology
TipRanks - Anthropic
HoldReiterates
$48.00 → $59.00
OpenAI Biotechnology
TipRanks - OpenAI
HoldReiterates
$49.00 → $61.00
DegenStock
StockTwits
BuyInitiates Coverage
-
Zacks Equity Research
Zacks Equity Research
BuyInitiates Coverage
-
Edward Tenthoff
Piper Sandler
BuyReiterates
$110.00
Tyler Van Buren
TD Cowen
HoldMaintains
$45.00
Luca Issi
RBC Capital
HoldMaintains
$50.00
Prosper Junior Bakiny
The Motley Fool
HoldInitiates Coverage
-
Silvan Turkcan
Citizens JMP
BuyMaintains
$80.00
Ekta Bagri
Zacks Equity Research
BuyInitiates Coverage
-
AlmostMiddleClass
StockTwits
BuyInitiates Coverage
-
Mitchell Kapoor
HC Wainwright
BuyReiterates
$80.00
Alec Stranahan
BofA Securities
BuyMaintains
$83.00
Brendan Coffey
The Motley Fool
BuyInitiates Coverage
-
Edmund Ingham
Forbes
BuyInitiates Coverage
-
Edward Tenthoff
Piper Sandler
BuyReiterates
$110.00
Gil Blum
Needham
BuyMaintains
$82.00

Frequently Asked Questions

What is the analyst consensus rating for CRSP?

The analyst consensus rating for CRSP is "Buy" based on 18 analyst recommendations.

What is the average price target for CRSP?

The average 12-month price target for CRSP is $72.22, representing an upside of 35.1% from the current price of $53.45.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.